Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Additional registration fee required

Faculty have requested this content not be shared on social media

CME Credit Offered

Poster Icons

Foundation Awardee

No Social Media

Back

Q&A

Education/Simulation

Poster Session 2

(632) Barriers to providing training in opioid use disorder: a survey of OB/GYN residency program directors

Tuesday, February 13, 2024

3:30 PM – 5:00 PM

Location: Prince George's Exhibit Hall CDE, Lower Atrium Level

Primary & Presenting Author(s)

Julia Whitley, MD

Washington University in St. Louis
St. Louis, MO

Coauthor(s)

JK

Jeannie C. Kelly, MD, FACOG, MS

Associate Professor
Washington University School of Medicine in St. Louis, Barnes Jewish Hospital
St. Louis, MO, United States
Megan L. Lawlor, MD

Washington University School of Medicine in St. Louis
St. Louis, MO, United States
KG

Karen George, MD, MPH

Larner College of Medicine at The University of Vermont
Burlington, VT, United States
EB

Erika Banks, MD

New York University Grossman Long Island School of Medicine
Mineola, NY, United States
PM

Phillip Ma, MD

George Washington University School of Medicine and Health Sciences
Washington, DC, United States
JC

Jillian Catalanotti, MD

George Washington University School of Medicine and Health Sciences
Washington, DC, United States

Objective: Medication-assisted therapy (MAT) is recommended for pregnant patients with OUD. Few OB/GYN residency programs offer MAT training. We aimed to characterize training offered and identify perceived barriers to MAT training among OB/GYN program directors (PDs).

Study Design: We administered a survey through email to all OB/GYN residency PDs asking whether they believe MAT is in-scope for OB/GYNs and perceived barriers in providing MAT training to residents. We collected PD demographic information including gender identity, race/ethnicity, age, and years as PD. We calculated number/percent for each response, and Fisher’s exact test was used to determine associations between demographic, personal, or program information and MAT-related responses.

Results: The overall response rate was 91.3%. The majority of PDs identified as female (73.9%) and white (74.3%), and 44.3% directed a university-based residency program. 62% of PDs agreed with the statement “Treating opioid use disorder with medication-assisted therapy is within the scope of practice of an OB/GYN.” 40.1% of PDs reported no faculty in their department prescribe MAT, 36.4% have a colleague who does, and 15.1% of PDs themselves prescribe MAT. The leading reported barrier to providing training was lack of trained faculty (81.6%), followed by lack of faculty interest (42.7%). A greater proportion of PDs from programs with ≤ 4 residents per year (42.2%, p=0.001) reported provision of MAT training, compared to PDs from programs with more than 10 residents per year (6.21%, p=0.02). A greater percentage of PDs from programs having between 5 and 7 residents per year (50.7%, p=0.02) identified a lack of trained faculty as a barrier to providing MAT training, compared with PDs from programs with ≤ 4 residents per year (30.4%, p=0.03).

Conclusion: Although most PDs agree that MAT is in-scope for an OB/GYN, a minority prescribe MAT or have a colleague who prescribes MAT. Lack of trained faculty is a major barrier to providing MAT training, and focused efforts in faculty education may help address this barrier.